يعرض 1 - 10 نتائج من 109 نتيجة بحث عن '"Reyners, AKL"', وقت الاستعلام: 0.87s تنقيح النتائج
  1. 1
  2. 2

    المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Targeted Gynaecologic Oncology (TARGON), Groningen Kidney Center (GKC), Vascular Ageing Programme (VAP)

    المصدر: European Journal of Applied Physiology, 82(5-6), 487-492. SPRINGER

    مصطلحات موضوعية: diving reflex, autonomic function, RESPONSES

  3. 3

    المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Targeted Gynaecologic Oncology (TARGON), Groningen Kidney Center (GKC), Vascular Ageing Programme (VAP), Translational Immunology Groningen (TRIGR)

    المصدر: Amyloid:International journal of experimental and clinical investigation, 5(3), 193-199. Taylor & Francis Ltd

  4. 4
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية

    المؤلفون: Meeuse JJ, Koornstra JJ, Reyners AKL

    المصدر: European Journal of Gastroenterology & Hepatology; 2010 Aug, Vol. 22 Issue 8, p942-945, 4p

  7. 7
    دورية أكاديمية
  8. 8
  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية

    المؤلفون: van der Kleij MBA; Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands. m.vd.kleij@nki.nl.; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. m.vd.kleij@nki.nl., Guchelaar NAD; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Meertens M; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Westerdijk K; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Centre, Nijmegen, The Netherlands., Giraud EL; Department of Pharmacy and Clinical Pharmacology, Research Institute for Medical Innovation, Radboud University Medical Centre, Nijmegen, The Netherlands., Bleckman RF; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Groenland SL; Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands., van Eerden RAG; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Imholz ALT; Department of Medical Oncology, Deventer Hospital, Deventer, The Netherlands., Vulink AJE; Department of Medical Oncology, Reinier de Graaf Hospital, Delft, The Netherlands., Otten HM; Department of Medical Oncology, Meander Medical Centre, Amersfoort, The Netherlands., Fiebrich-Westra HB; Department of Medical Oncology, Isala Hospital, Zwolle, The Netherlands., Lubberman FJE; Department of Pharmacy, Gelderse Vallei Hospital, Ede, The Netherlands., Desar IME; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Centre, Nijmegen, The Netherlands., Moes DAR; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Centre, Leiden, The Netherlands., Touw DJ; Department of Clinical Pharmacy and Pharmacology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Pharmacy, Erasmus University Medical Centre, Rotterdam, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands., Reyners AKL; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., van Erp NP; Department of Pharmacy and Clinical Pharmacology, Research Institute for Medical Innovation, Radboud University Medical Centre, Nijmegen, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Huitema ADR; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, Utrecht University Medical Centre, Utrecht, The Netherlands.; Department of Pharmacology, Princess Máxima Centre for Paediatric Oncology, Utrecht, The Netherlands., Steeghs N; Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Department of Medical Oncology, Utrecht University Medical Centre, Utrecht University, Utrecht, The Netherlands.

    مؤلفون مشاركون: Dutch Pharmacology Oncology Group (DPOG)

    المصدر: British journal of cancer [Br J Cancer] 2024 Jul 06. Date of Electronic Publication: 2024 Jul 06.

    نوع المنشور: Journal Article

    بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE